AZYO - Aziyo Biologics GAAP EPS of -$0.49 beats by $0.05 revenue of $13.1M misses by $0.6M
2023-05-10 16:14:49 ET
- Aziyo Biologics press release ( NASDAQ: AZYO ): Q1 GAAP EPS of -$0.49 beats by $0.05 .
- Revenue of $13.1M (+13.9% Y/Y) misses by $0.6M .
- Gross profit for the first quarter of 2023 was $6.3 million and gross margin was 49%, as compared to $4.3 million and 37%, respectively, in the corresponding prior-year period.
-
Total operating expenses were $12.7 million for the first quarter of 2023, as compared to $11.2 million in the corresponding prior-year period.
-
Aziyo’s cash balance as of March 31, 2023, was $11.8 million
For further details see:
Aziyo Biologics GAAP EPS of -$0.49 beats by $0.05, revenue of $13.1M misses by $0.6M